Please login to the form below
NHS
This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.
Novartis announces delay in UK cholesterol drug study
In January 2020, Novartis announced that it had teamed up with the UK’s National Health Service (NHS) on a clinical trial – ORION-4 – of the drug. ... The trial is utilising NHS data to identify patients across the country who are at risk of
Latest news
-
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
NHS. The cost-effectiveness watchdog has backed the use of Ultomiris (ravulizumab) to treat PNH in adults with haemolysis with clinical symptoms suggesting high disease activity, or whose disease is clinically ... Compared with Alexion’s older drug,
-
Moderna’s booster vaccine for South African variant demonstrates promising early results
The NHS said in a statement that over 27 million people in England have received their first COVID-19 jab, and over 6.1 million second doses have also been administered ... The Moderna rollout marks another milestone in the vaccination programme,” said
-
UK plans to launch new national health agency focused on tackling pandemics
The UK Health Security Agency (UKHSA) will protect against future health threats, and will take over the COVID-19 pandemic response from Public Health England (PHE) and NHS Test and Trace. ... At that time, the agency was set to be led by Baroness Dido
-
UK COVID-19 vaccination drive hit with supply delays over the coming weeks
NHS England officials issued a letter to organisations within the health service yesterday, saying that it has been notified that there will be a ‘significant reduction’ in the weekly vaccine supply
-
Novartis and NHS England reach ‘landmark’ deal for Zolgensma gene therapy for SMA
This recommendation advises the use of Zolgensma on the NHS for babies aged up to 12 months with SMA type 1 before they develop symptoms. ... According to NHS England, up to 80 patients will be able to benefit from treatment with Zolgensma each year.
More from news
Approximately 372 fully matching, plus 1,789 partially matching documents found.
Latest Intelligence
-
Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England
focus on the single technology appraisal [STA] and the highly specialised technology [HST] frameworks), or, second, via NHS England specialised commissioning. ... 80.9%; 17/21) compared with drugs evaluated by NHS England for specialised commissioning (61
-
Setting up for success in a post-Brexit, post-pandemic Britain
In the UK, we are fully aware of the great work that our NHS delivers and, most importantly, the crucial need to deliver medicines to patients quickly and effectively. ... Recently, Galapagos and Gilead Sciences received a positive NICE recommendation
-
A new era for UK-Japanese scientific research relations
The Association for the British Pharmaceutical Industry (ABPI) has made recommendations to the UK Government, including increased investment for the NIHR, HRA and MHRA, better utilising the NHS’s vast healthcare
-
The value of Patient Support Programmes
A recent NHS-led survey reported that doctors do see value in some of the content offered by PSPs, although this was mostly limited to specific practical support such as injection
-
Mapping the patient journey: eight ways to improve support programmes
But challenges still remain. An NHS Confederation briefing in November 2018 noted the value of PSPs but cited lack of awareness among HCPs and patients as a common barrier to their
More from intelligence
Approximately 34 fully matching, plus 187 partially matching documents found.
Latest appointments
-
akt health communications hires Heather Tarplee as senior account director
Tarplee brings significant healthcare PR experience to akt health, including in leading large teams to deliver national health campaigns for public sector clients, such as Public Health England, NHS England and
-
NICE looks internally for new chief executive
During her time at NICE, she held responsibility for setting up and running the clinical guidelines programme, and for establishing the NICE implementation function and launching NHS Evidence.
-
Four Health announces a pair of internal promotions
Springham (pictured left) has more than a decade of experience within the health sector, gained from leading teams within international publishers and the NHS. ... role of the NHS in public health and prevention medicine.
-
Porterhouse announces members of medical advisory group
She graduated from St Bartholomew’s and the London School of Medicine and Dentistry in 2001, working as a pathologist in the NHS until 2015.
-
New faces at Lucid Group and ZPB Associates
Following two years working to integrate the new guidance into NHS organisations, Goodwin moved into the pharmaceutical sector. ... The agency’s combined teams have a wealth of experience with team members having previously worked at hospital trusts,
More from appointments
Approximately 18 fully matching, plus 89 partially matching documents found.
Latest from PMHub
-
5 ways that lockdowns and restrictions could be affecting our allergies
Accessed April 23, 2021. Rotherham NHS Clinical Commissioning Group; 2020. Resource.
-
How does the government plan to reshape the NHS?
Integrated care. The white paper confirms that NHS England (NHSE) is backing legislation to abolish Clinical Commissioning Groups (CCGs). ... value propositions help the NHS to improve patient outcomes and also deliver on wider priorities.
-
WHITE PAPER: Why do men die younger?
13. Public Health England and the NHS have a distinct lack of mission statements on the topic. ... calls for increased efforts from all stakeholders: from NHS England, to GPs, to men themselves.
-
Integrated NHS finances: what do they mean for High Cost Drugs?
NHS England (NHSE) Specialised Commissioning will continue to retain the budget for cancer and certain rare diseases. ... For these services, most High Cost Drugs will still be contracted via NHS England.
-
WHITE PAPER: What's missing in women's health?
NHS. https://www.nhs.uk/conditions/. hormone-replacement-therapy-hrt/. Accessed March 4, 2020. 4. Menopause – Treatment. ... NHS. https://www.nhs.uk/conditions/menopause/. treatment/. Accessed December 23, 2019. 5. Menopause. NICE CKS.
More from PMHub
Approximately 45 fully matching, plus 236 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Senior & Principal Medical Writer
-
Competitive Salary Offered
-
Senior Medical Writer
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Account Management
-
Competitive Salary Offered
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Associate Account Director
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
-
Medical Editor
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- GSK’s revenue drops by 18% in Q1 as performance pressures mount
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
- Live Webinar: Blockchain in Healthcare: Predictions for the Post-COVID World
- Live Webinar: Digital Health for Improving Care in Disadvantaged Populations
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Illingworth Research Group wins ‘prestigious’ Queen’s Award
- Working in true partnership in a time of change
- Live Webinar: The Future of Digital Pills
- Total COVID-19 vaccine spending to reach $157bn by 2025, says report
- NICE sets out plans for ‘ambitious’ five-year strategy
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
- PMEA 2021 has officially launched – with a new online entry system
PMHub
Onyx Health Ltd
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
